Skip to main contentSkip to navigation
Sirius Investors
Therapeutics Acquisition Corp.

Therapeutics Acquisition Corp.

RACA
NASDAQFinancial Services

Market Capitalization & Enterprise Value

Research-grade valuation history for RACA. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
211.39M
0.00% over period

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
210.29M
0.00% over period

Market Cap History

Investor Valuation Insights

As of Jun 30, 2021

EV/EBITDA

Potentially Cheap

0.00x

Lower EV/EBITDA can indicate attractive valuation relative to operating earnings.

EV vs Market Cap Spread

-1.09M

EV is -0.5% vs equity value

Capital Structure Signal

Net Cash Profile

EV premium trend: +0.0 pp vs earliest data

Additional Multiples

EV/Sales: 0.00x

Net Debt/EBITDA: 0.00x

Share count change in dataset: +0.00%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Dec 31, 2020211.39M210.29M$13.9215.19M

Enterprise Value Analysis

Analysis unavailable

Not enough valid data points for analysis
Insufficient data